Financial Ratios Verici Dx plc
Equities
VRCI
GB00BM8HZD43
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7200 GBX | -0.69% |
|
-0.69% | -0.69% |
| 02-05 | EARNINGS AND TRADING: React sales increase; Arcontech profit declines | AN |
| 02-05 | Verici Dx's Tutivia Added as In-network Test Under BCBS Deal | MT |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Profitability | |||||
Return on Assets | - | -27.82 | -49.55 | -48.36 | -50.81 |
Return on Total Capital | - | -29.94 | -57.54 | -64.5 | -77.96 |
Return On Equity % | - | -52.71 | -97.11 | -115.94 | -133.15 |
Return on Common Equity | - | -52.71 | -97.11 | -115.94 | -133.15 |
Margin Analysis | |||||
Gross Profit Margin % | - | - | - | 100 | 100 |
SG&A Margin | - | - | - | 848.77 | 260.83 |
EBITDA Margin % | - | - | - | -748.77 | -160.83 |
EBITA Margin % | - | - | - | -815.2 | -176.46 |
EBIT Margin % | - | - | - | -830.6 | -181.82 |
Income From Continuing Operations Margin % | - | - | - | -862.19 | -175.92 |
Net Income Margin % | - | - | - | -862.19 | -175.92 |
Net Avail. For Common Margin % | - | - | - | -862.19 | -175.92 |
Normalized Net Income Margin | - | - | - | -510.92 | -109.3 |
Levered Free Cash Flow Margin | - | - | - | -375.21 | -117.22 |
Unlevered Free Cash Flow Margin | - | - | - | -373.42 | -116.81 |
Asset Turnover | |||||
Asset Turnover | - | - | - | 0.09 | 0.45 |
Fixed Assets Turnover | - | - | - | 0.6 | 3.01 |
Short Term Liquidity | |||||
Current Ratio | 26.51 | 6.09 | 4.58 | 1.14 | 2.24 |
Quick Ratio | 26.21 | 5.87 | 4.43 | 1.07 | 2.02 |
Operating Cash Flow to Current Liabilities | -1.88 | -3.51 | -4.47 | -2.04 | -2.95 |
Long Term Solvency | |||||
Total Debt/Equity | 0.37 | - | 6.08 | 15.18 | 7.05 |
Total Debt / Total Capital | 0.37 | - | 5.73 | 13.18 | 6.58 |
LT Debt/Equity | - | - | 4.73 | 10.6 | 3.59 |
Long-Term Debt / Total Capital | - | - | 4.46 | 9.2 | 3.35 |
Total Liabilities / Total Assets | 3.36 | 13.08 | 19.55 | 52.2 | 29.72 |
EBIT / Interest Expense | -22.88 | - | -2.23K | -290.14 | -275.95 |
EBITDA / Interest Expense | -20.12 | - | -2.1K | -261.55 | -244.09 |
(EBITDA - Capex) / Interest Expense | -20.5 | - | -2.31K | -262.34 | -244.86 |
Total Debt / EBITDA | -0.03 | - | -0.07 | -0.07 | -0.07 |
Net Debt / EBITDA | 8.4 | 1.45 | 0.87 | 0.28 | 0.69 |
Total Debt / (EBITDA - Capex) | -0.03 | - | -0.06 | -0.07 | -0.07 |
Net Debt / (EBITDA - Capex) | 8.25 | 1.33 | 0.79 | 0.28 | 0.68 |
Growth Over Prior Year | |||||
Total Revenues, 1 Yr. Growth % | - | - | - | - | 229.62 |
Gross Profit, 1 Yr. Growth % | - | - | - | - | 229.62 |
EBITDA, 1 Yr. Growth % | - | 239.83 | 46.79 | -27.74 | -29.2 |
EBITA, 1 Yr. Growth % | - | 225.28 | 47.65 | -24.89 | -28.65 |
EBIT, 1 Yr. Growth % | - | 217.17 | 46.75 | -24.45 | -27.85 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 17.28 | 36.96 | -23.43 | -32.75 |
Net Income, 1 Yr. Growth % | - | 17.28 | 36.96 | -23.43 | -32.75 |
Normalized Net Income, 1 Yr. Growth % | - | 203.89 | 46.12 | -25.32 | -29.49 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | -28.24 | 17.89 | -25.97 | -50.76 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 69.32 | 155.73 | -32.19 | -37.05 |
Total Assets, 1 Yr. Growth % | - | -32.09 | 3.74 | -47.97 | 0.66 |
Tangible Book Value, 1 Yr. Growth % | - | -44.13 | -4.4 | -84.62 | 117.86 |
Common Equity, 1 Yr. Growth % | - | -38.93 | -3.97 | -69.09 | 47.98 |
Cash From Operations, 1 Yr. Growth % | - | 394.46 | 58.9 | -28.88 | -15.92 |
Capital Expenditures, 1 Yr. Growth % | - | 1.49K | 68.28 | -97.79 | -26.09 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | 87.76 | -44.8 | 2.98 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | 87.68 | -45.04 | 3.11 |
Compound Annual Growth Rate Over Two Years | |||||
EBITDA, 2 Yr. CAGR % | - | - | 123.34 | 2.99 | -28.48 |
EBITA, 2 Yr. CAGR % | - | - | 119.14 | 5.31 | -26.79 |
EBIT, 2 Yr. CAGR % | - | - | 115.74 | 5.3 | -26.17 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | 26.73 | 2.4 | -28.24 |
Net Income, 2 Yr. CAGR % | - | - | 26.73 | 2.4 | -28.24 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 110.72 | 4.46 | -27.44 |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | -8.03 | -6.58 | -39.63 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 108.12 | 31.69 | -34.67 |
Total Assets, 2 Yr. CAGR % | - | - | -16.07 | -26.53 | -27.63 |
Tangible Book Value, 2 Yr. CAGR % | - | - | -26.91 | -61.66 | -42.12 |
Common Equity, 2 Yr. CAGR % | - | - | -23.42 | -45.51 | -32.36 |
Cash From Operations, 2 Yr. CAGR % | - | - | 180.3 | 6.3 | -22.67 |
Capital Expenditures, 2 Yr. CAGR % | - | - | 417.88 | -80.71 | -87.21 |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 1.81 | -24.61 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | 1.56 | -24.72 |
Compound Annual Growth Rate Over Three Years | |||||
EBITDA, 3 Yr. CAGR % | - | - | - | 53.32 | -9.11 |
EBITA, 3 Yr. CAGR % | - | - | - | 53.37 | -7.51 |
EBIT, 3 Yr. CAGR % | - | - | - | 52.07 | -7.17 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | 7.14 | -10.99 |
Net Income, 3 Yr. CAGR % | - | - | - | 7.14 | -10.99 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | 49.12 | -8.37 |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | -14.45 | -24.54 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 43.21 | 2.96 |
Total Assets, 3 Yr. CAGR % | - | - | - | -28.43 | -18.4 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | -56.53 | -31.58 |
Common Equity, 3 Yr. CAGR % | - | - | - | -43.4 | -23.98 |
Cash From Operations, 3 Yr. CAGR % | - | - | - | 77.45 | -1.69 |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | -15.98 | -69.81 |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 2.2 |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | - | 2.08 |
- Stock Market
- Equities
- VRCI Stock
- Financials Verici Dx plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















